Status: current, Defined. Date: 31-Jan 2009. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1205284011 | Natamycin ophthalmic preparation (product) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 150245019 | Natamycin ophthalmic preparation | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 150246018 | Pimaricin ophthalmic preparation | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3658838013 | Product containing natamycin in ocular dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3658839017 | Product containing natamycin in ocular dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3658840015 | Natamycin in ocular dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3710977014 | Product containing natamycin in ocular dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3710978016 | Natamycin-containing product in ocular dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 833809011 | Natamycin ophthalmic preparation (substance) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Natamycin-containing product in ocular dose form | Plays role | Antifungal therapeutic role | true | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Is a | Ophthalmic antibiotic | false | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Has active ingredient | Skin antifungal agent | false | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Has active ingredient | Natamycin ophthalmic preparation | false | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Has active ingredient | Skin agent | false | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Has active ingredient | Natamycin | true | Inferred relationship | Some | 1 | |
| Natamycin-containing product in ocular dose form | Has active ingredient | Local anti-infective | false | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Has active ingredient | Skin agent | false | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Is a | Natamycin-containing product | true | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Has manufactured dose form | Ocular dose form | true | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Is a | Ophthalmic anti-infective preparation | false | Inferred relationship | Some | ||
| Natamycin-containing product in ocular dose form | Is a | Product manufactured as ocular dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Natamycin only product in ocular dose form | Is a | True | Natamycin-containing product in ocular dose form | Inferred relationship | Some | |
| Natamycin 50 mg/mL eye suspension | Is a | False | Natamycin-containing product in ocular dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR